Apogem Capital’s BayCom BCML Stock Holding History

Apogem Capital’s Portfolio BCML Stock Details BCML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-171,160	Closed	-$3.08M	–	191
2021 Q1	$3.08M	Hold	171,160	–	–	2.09%	4
2020 Q4	$2.6M	Buy	+171,160	New	+$2.33M	1.73%	12

Other funds holding BCML

EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Basswood Capital Management New York $2.12B AUM 19.53% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ACM

Ategra Capital Management Vienna, Virginia $201M AUM 23.33% 1-Year Est. Return

FCM

FJ Capital Management Mclean, Virginia $888M AUM 18.97% 1-Year Est. Return

Apogem Capital's BCML Position: Q2 2021 in Review

Apogem Capital sold out of BayCom (BCML) in Q2 2021, closing a stake of 171,160 shares — an estimated $3.08M sold.

Apogem Capital first reported a position in BCML in Q4 2020 and held it in 2 quarters. The position peaked at $3.08M in Q1 2021. 63 funds tracked by Wall St. Rank hold BCML as of Q2 2021.

Apogem Capital reported no remaining BayCom position as of Q2 2021 after selling out during the quarter.
Apogem Capital sold 171,160 BayCom shares in Q2 2021, an estimated $3.08M.
Apogem Capital first reported a position in BayCom in Q4 2020 and held it in 2 quarters.
Apogem Capital's BayCom position peaked at $3.08M in Q1 2021.
63 funds tracked by Wall St. Rank held BayCom as of Q2 2021.

Based on Apogem Capital's 13F filing for Q2 2021, filed 16 Aug 2021.